We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Molecular Templates Inc (MTEM) USD0.001

Sell:$1.41 Buy:$1.87 Change: $0.015 (1.01%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:$1.41
Buy:$1.87
Change: $0.015 (1.01%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:$1.41
Buy:$1.87
Change: $0.015 (1.01%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Molecular Templates, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. The Company’s proprietary drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer. Its product pipeline includes MT-6402, MT-8421 and MT-0169. MT-6402 is an ETB consisting of a single chain variable fragments (scFv), with affinity for PD-L1, fused to the enzymatically active de-immunized SLTA and a HLA-A*02 class I antigen derived from the human cytomegalovirus (HCMV) pp65 protein. MT-8421, its ETB targeting CTLA-4, along with MT-6402. MT-0169 is designed to destroy CD38+ tumour cells through internalization of CD38 and cell destruction via a novel mechanism of action (enzymatic ribosomal destruction and immunogenic cell death).

Contact details

Address:
9301 Amberglen Blvd Ste 100
AUSTIN
78729-1153
United States
Telephone:
+1 (512) 8961555
Website:
https://mtem.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MTEM
ISIN:
US6085502085
Market cap:
$10.40 million
Shares in issue:
6.58 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Jason Kim
    President, Chief Financial Officer
  • Eric Poma
    Chief Executive Officer, Chief Scientific Officer, Director
  • Kristen Quigley
    Chief Operating Officer
  • Grace Kim
    Chief Strategy Officer and Head of Investor Relations
  • Maurizio Voi
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.